• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Study Identifies Trends Contributing to Clinical Trial Transformation

Study Identifies Trends Contributing to Clinical Trial Transformation

April 29, 2019
John Mitchell

A report from IQVIA has identified eight drivers of clinical development the company says will reach “peak impact” over the next two to four years.

  1. Digital health technologies will capture drug efficacy and safety data remotely to improve patient safety, enable virtual trial formats and ease site burdens.
  2. The availability of pre-screened patient pools and direct-to-patient recruitment will enable trials to meet enrollment targets, decrease trial duration and accelerate market availability.
  3. Predictive analytics and artificial intelligence technologies and methods will help identify new clinical hypotheses, reduce trial risk and speed enrollment by identifying protocol-ready patients.
  4. Increased focus on patient-reported outcomes will provide new insight into the patient experience, including drug efficacy and safety outside the clinical setting.
  5. Real-world data will contribute to all aspects of accelerating clinical trials, from optimizing trial design to site selection, and will drive real-world evidence registries and serve as a virtual control arm for trials.
  6. Use of targeted therapies and next-generation biotherapeutics — which have more than doubled over the past three years — also will speed trials and improve efficacy, as well as success rates. However, longer patient follow-up times will be required.
  7. Biomarker testing will be used more widely to better target trial patient populations. The field is expected to yield a 34 percent increase across therapy areas and trial phases, with a corresponding success rate of 27 percent.
  8. Regulatory support for precision medicine, as well as novel trial designs and endpoints, will contribute to accelerated drug approvals.

Read the full report at: https://bit.ly/2XK4OvA.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

  • VaccinewithNeedle-360x240.png

    2021 Vaccine Industry Will Continue to be Dominated by COVID-19 Trials, Experts Say

  • Dominate-360x240.png

    COVID-19, Oncology, CNS and Infectious Disease Trials Will Dominate in 2021, Survey Predicts

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing